The Relationship With Mad Honey Containing Grayanotoxin and Ovary Tissue

Sponsor
Celal Bayar University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05643599
Collaborator
(none)
18
1
30
18.3

Study Details

Study Description

Brief Summary

For our working group, eighteen healthy Sprague-Dawley female rats were recruited and separated into three groups in an experimental animal laboratory.

Group 1 was given mad honey (n:6) (80 mg/kg); Group 2 was given normal honey (n:6) (80 mg/kg), and Group 3 was the control group (n:6). The groups were given normal and mad honey by oral gavage for 30 days in this study. Rats were anesthetized intramuscularly with 50 mg/kg ketamine and 5 mg/kg xylazine on the 30th day of the study. At the conclusion of the study, female rats in the proestrus phase of the estrous cycle (as indicated by vaginal smear) were sacrificed and their ovarian tissues were placed in neutral formalin solution.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Mad Honey
  • Dietary Supplement: Normal Honey
  • Dietary Supplement: Control

Detailed Description

Honey poisoning is caused by consuming honey produced by bees that feed on Rhododendron family plants. Rhododendron poisoning goes by names such as mad honey poisoning or grayanotoxin poisoning. The purpose of this study is to determine the effects of grayanotoxin in mad honey on ovarian tissue folliculogenesis in terms of cell death and nitric oxide expression. Three groups of 18 female Sprague-Dawley rats were formed. The first group received mad honey (80 mg/kg), the second group received normal honey (80 mg/kg), and the third group is control. The first and second groups received normal and mad honey by oral gavage for 30 days before being sacrificed under anesthesia The caspase 3 immunostaining group observed a moderate to a strong response, particularly in the granulosa cells of the Graaf follicles in the mad honey group, while the normal honey and control groups observed a weak to moderate reaction. In the mad honey group, immunostaining for caspase8 and caspase 9 revealed a moderate immunoreaction in the granulosa cells of the Graaf follicles, while expression was weak in the normal honey and control groups. The TUNEL approach revealed that the majority of Graaf follicles that exhibited TUNEL positive in the mad honey group and progressed to atresia were Graaf follicles. The iNOS immunoreaction revealed a high level of expression in the mad honey group, particularly in several Graaf follicles. In all three groups, a weak reactivity to eNOS immunostaining was seen in both Graaf follicles and theca external layers. According to the findings of apoptotic and nitric oxide marker expression, it was determined that mad honey may result in an increase in follicular atresia in ovarian follicles when compared to normal honey and control groups.

Study Design

Study Type:
Observational
Anticipated Enrollment :
18 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
The Relationship Between Oxidative Stress and Apoptosis of Histopathological Changes Made by Mad Honey Containing Grayanotoxin in the Ovary
Actual Study Start Date :
Dec 1, 2022
Anticipated Primary Completion Date :
Dec 15, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Group 1:

Mad honey

Dietary Supplement: Mad Honey
mad honey (80 mg/kg); (n:6)

Group 2:

Normal honey

Dietary Supplement: Normal Honey
normal honey (80 mg/kg),(n:6)

Group 3:

without intervention

Dietary Supplement: Control
Control

Outcome Measures

Primary Outcome Measures

  1. Comparison of the Mad Honey and Normal Honey findings of the ovary tissue specimens [Baseline]

    Analyses of the relationship between oxidative stress and apoptosis of histopathological changes made by mad honey containing grayanotoxin in the ovary

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Weeks to 10 Weeks
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy rats
Exclusion Criteria:
  • patient rats

  • not eating rats

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hayrunnisa Yunusemre Manì‡sa Turkey 45030

Sponsors and Collaborators

  • Celal Bayar University

Investigators

  • Study Chair: Gulsen Gurgen, Manisa Celal Bayar University
  • Study Chair: Suha Turkmen, Karadeniz Teknik University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hayrunnisa Yesil Sarsmaz, Asistant Prof., Celal Bayar University
ClinicalTrials.gov Identifier:
NCT05643599
Other Study ID Numbers:
  • MCBU_Madhoney
First Posted:
Dec 8, 2022
Last Update Posted:
Dec 20, 2022
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hayrunnisa Yesil Sarsmaz, Asistant Prof., Celal Bayar University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 20, 2022